Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.

[1]  H. Sprong,et al.  Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe , 2018, Emerging infectious diseases.

[2]  G. Wormser,et al.  Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Platonov,et al.  In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi , 2018, Antimicrobial Agents and Chemotherapy.

[4]  R. Dessau,et al.  Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  G. Shipulin,et al.  [Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen]. , 2017, Terapevticheskii arkhiv.

[6]  P. Krause,et al.  Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study. , 2017, CMAJ open.

[7]  C. Visser,et al.  In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents , 2017, Antimicrobial Agents and Chemotherapy.

[8]  Silvio C. E. Tosatto,et al.  InterPro in 2017—beyond protein family and domain annotations , 2016, Nucleic Acids Res..

[9]  D. McKenna,et al.  Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology. , 2016, Diagnostic microbiology and infectious disease.

[10]  V. Fingerle,et al.  Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised Person , 2016, Emerging infectious diseases.

[11]  T. van der Poll,et al.  Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi , 2016, The Journal of Immunology.

[12]  R. Dessau,et al.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis , 2016, BMC Infectious Diseases.

[13]  S. Telford,et al.  Borrelia miyamotoi Disease in the Northeastern United States , 2015, Annals of Internal Medicine.

[14]  H. Sprong,et al.  Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete. , 2015, Trends in parasitology.

[15]  J. Hovius,et al.  Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  H. Horlings,et al.  A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe , 2013, The Lancet.

[17]  S. Telford,et al.  Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. , 2013, The New England journal of medicine.

[18]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[19]  P. Krause,et al.  Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia , 2011, Emerging infectious diseases.

[20]  A. Steere,et al.  Serodiagnosis of Lyme Disease by Kinetic Enzyme-Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens of Borrelia burgdorferi Compared with 2-Tiered Testing Using Whole-Cell Lysates , 2003, The Journal of infectious diseases.

[21]  A. Steere,et al.  Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE , 1999, Journal of Clinical Microbiology.

[22]  D. E. Anderson,et al.  GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis , 1996, Journal of clinical microbiology.

[23]  Y. Takahashi,et al.  Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. , 1995, International journal of systematic bacteriology.

[24]  A. Steere,et al.  Lyme borreliosis. , 2016, Nature reviews. Disease primers.

[25]  A. Platonov,et al.  [Clinical presentation of "new" tick-borne borreliosis caused by Borrelia miyamotoi]. , 2012, Terapevticheskii arkhiv.